Literature DB >> 19015436

Sunitinib and periodic hair depigmentation due to temporary c-KIT inhibition.

Jörg Thomas Hartmann, Lothar Kanz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015436     DOI: 10.1001/archderm.144.11.1525

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  16 in total

1.  Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.

Authors:  Davorka Messmer; Jessie-F Fecteau; Morgan O'Hayre; Ila S Bharati; Tracy M Handel; Thomas J Kipps
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

2.  The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.

Authors:  Meredith Cummins; Nick Pavlakis
Journal:  Ther Adv Med Oncol       Date:  2013-09       Impact factor: 8.168

Review 3.  [Skin changes as a result of targeted therapies in oncology patients: cutaneous side effects of targeted therapies in oncology patients].

Authors:  K C Kähler; A Hauschild
Journal:  Hautarzt       Date:  2009-05       Impact factor: 0.751

Review 4.  [Cutaneous reactions to molecular targeted therapies].

Authors:  C Pföhler; S Ugurel
Journal:  Hautarzt       Date:  2008-10       Impact factor: 0.751

5.  Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Authors:  Rena C Zuo; Andrea B Apolo; John J DiGiovanna; Howard L Parnes; Corrine M Keen; Swati Nanda; William L Dahut; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-02       Impact factor: 10.282

Review 6.  Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Authors:  Julia Dai; Viswanath R Belum; Shenhong Wu; Vincent Sibaud; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09-14       Impact factor: 11.527

7.  Gefitinib-induced intestinal obstruction in advanced non-small cell lung carcinoma: A case report.

Authors:  Yi-Chen Liang; Gang Wu; Jing Cheng; Dan-Dan Yu; Hong-Ge Wu
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

Review 8.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

Review 9.  Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).

Authors:  Emily L Coleman; Brianna Olamiju; Jonathan S Leventhal
Journal:  Oncol Rep       Date:  2020-12-24       Impact factor: 3.906

10.  Sunitinib induced pyoderma gangrenosum-like ulcerations.

Authors:  S Akanay-Diesel; N P Hoff; S Kürle; J Haes; A Erhardt; D Häussinger; K-W Schulte; Edwin Bölke; C Matuschek; W Budach; P A Gerber; B Homey
Journal:  Eur J Med Res       Date:  2011-11-10       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.